Strathclyde Institute Of Pharmacy And Biomedical Sciences

Organisational unit: Department

1 - 10 out of 10Page size: 10
Sort by: Title
  1. Bee venom research drives industrial Drug Discovery initiative in Republic of Korea

    Mark Dufton (Participant), David Watson (Participant), John Parkinson (Participant)

    Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

  2. Commercialisation of non-invasive wound monitoring system leads to quality of life benefits to patients.

    Patricia Connolly (Participant), Iain Hunter (Participant)

    Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

  3. Economic benefit and competitive advantage from commercial adoption of an innovative non-invasive delivery method for drugs and vaccines

    Katharine Carter (Participant), Valerie Ferro (Participant), Alexander Mullen (Participant), James Alexander (Participant)

    Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

  4. Illicit drug analysis as a tool to combat global organised crime

    Niamh Nic Daeid (Participant), David Littlejohn (Participant), William Kerr (Participant), Oliver Brook Sutcliffe (Participant), Katy Savage (Participant), W. Meier-Augenstein (Participant)

    Impact: Impact - for External PortalQuality of life and safety, Economic and commerce, Professional practice, training and standards

  5. Images of Research 2015 Public and Urban Health category winner

    Kirsty Ross (Main contact), Catherine Lawrence (Participant), Iain McInnes (Participant)

    Impact: Impact - for External PortalCulture and creativity, Public understanding, information and debate, Education

  6. Improved health and survival rates for patients with malignant brain and prostate cancer, and economic benefit from new chemotherapy treatments.

    Gavin Halbert (Participant)

    Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

  7. Improved patient care through new guidelines for antibiotic dosing and monitoring.

    Alison Thomson (Participant)

    Impact: Impact - for External PortalProfessional practice, training and standards, Health and welfare - new products, guidelines and services

  8. Improving palliative care through better engagement of community pharmacies.

    Marion Bennie (Participant), Gazala Akram (Participant), Stephen Hudson (Participant)

    Impact: Impact - for External PortalQuality of life and safety, Health and welfare - new products, guidelines and services, Professional practice, training and standards

  9. MGB Biopharma licensed to treat deadly infections

    Colin Suckling (Participant), Iain Hunter (Participant), Alan Harvey (Participant), Simon MacKay (Participant), Curtis G. Gemmell (Participant)

    Impact: Impact - for External PortalEconomic and commerce, Health and welfare - new products, guidelines and services

  10. Public engagement/education with p4 pupils at Kelvindale Primary School

    Susan Chalmers (Participant)

    Impact: Impact - for External PortalEducation, Public understanding, information and debate